Pharvaris NV () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Keros Therapeutics, Inc.

Ligand Pharmaceuticals, Inc.

Innoviva, Inc.

Collegium Pharmaceutical, Inc.

ImmunityBio, Inc.

Ardelyx, Inc.

Revance Therapeutics, Inc.

Morphic Holding, Inc.

Pharvaris NV

ACELYRIN, Inc.

Intercept Pharmaceuticals, Inc.

Why is Pharvaris NV ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Pharvaris NV for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Pharvaris NV

66.88%

0.93

67.39%

S&P 500

16.12%

0.77

19.29%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

-220.14%

EBIT to Interest (avg)

-117.91

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.05

Sales to Capital Employed (avg)

Tax Ratio

1.51%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

87.72%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

4.70

EV to EBIT

-7.25

EV to EBITDA

-7.26

EV to Capital Employed

-67.36

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-49.29%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bullish

No Trend

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company

OPERATING CASH FLOW(Y)

Highest at USD -72.82 MM

NET PROFIT(HY)

Higher at USD -94.95 MM

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at -105.27 %

-11What is not working for the Company

INTEREST(HY)

At USD 0.1 MM has Grown at 393.92%

NET PROFIT(9M)

At USD -143.72 MM has Grown at -32.78%

Here's what is working for Pharvaris NV

Net Profit

Higher at USD -94.95 MM

than preceding 12 month period ended Sep 2025

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Operating Cash Flow

Highest at USD -72.82 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Debt-Equity Ratio

Lowest at -105.27 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost

Fallen by 0% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Pharvaris NV

Interest

At USD 0.1 MM has Grown at 393.92%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)